- 4th - 45th May 2023
- London, UK
9th RWE, Market Access, Pricing & Reimbursement Global Congress 2023 Europe
Trends and Strategies to Achieve Optimum Patient Access to Healthcare
- 00Days
- 00Hours
- 00Minutes
- 00Seconds
Dear Colleagues,
On a global scale, the pharmaceutical market is expected to grow in the years to come regardless of a recent slowdown in key markets across the globe. The increase is exacerbated by the growing and ageing population in key markets. Aside from this, increasing access to Pharmaceuticals to poor and middle-class families due to increases in disposable income also drives the industry’s growth. Pharma companies focusing on Rare and speciality medicines is another aspect leading the growth. Innovations attracting investments even from non-pharma companies are also sustaining the growth in the pharmaceutical industry.
The pharmaceutical industry is one of the major players in the healthcare sector. Payers want to provide access and fund innovative treatments to improve patient care but governments across Europe are struggling to balance the desire to provide timely access to innovative medicines with the need to contain healthcare spending due to the increasing pressure between the demands of the EU, national governments and regional authorities.
As healthcare budgets are continuously rising in Europe, governments implement a wide variety of policies to control them with the help of different public regulatory bodies that are involved in pharmaceutical coverage decisions across Europe. International collaboration among HTA and regulatory bodies can promote knowledge exchange, as do the actions payers take in an effort to reduce costs while maintaining quality care.
The upcoming 2023 RWE, Market Access, Pricing and Reimbursement Global Congress Europe will present a dynamic approach to key trends and insights on market access, health
technology assessment, real-world data, patient access, pricing and reimbursement on the current European landscape.
This year, we are putting together an agenda that addresses “Trends and Strategies to Achieve Optimum Patient Access to Healthcare”. We are gathering together high calibre expert speakers to participate and share their knowledge and expertise through Keynote Presentations and Panel discussions, addressing all aspects of the industry.
We look forward to welcoming you to the RWE, MAPR 2023 congress!
Sincerely yours,
Jocelyn is Conference Director at Paradigm Global Events (PGE). She has over 15+ years experience in organizing pharma-industry conferences and has been at the helm of every PGE conference since 2013. Jocelyn is based in London, UK.
Why you should attend:
You Will Meet:
WHO SHOULD ATTEND:
Network with members of boards, VP’s, Directors, Heads/Chiefs and Senior Managers of leading biopharmaceutical and biotech companies, government, CRO and solution providers involved in:
2023 Speakers
Vice President, Global Value Demonstration, Market Access & Pricing
Global Head - Market Access Policy
Global Pricing Head - BioPharmaceuticals
Head of Access Solutions & Pricing, New Markets
VP, Global HEOR, Medical Operations & Excellence
Head, Global Pricing Oncology, Global Market Access & Pricing
Market Access Director, UK & Ireland
Vice President
Global Market Access Director
Global Market Access Academy Lead
Sr. Director
Executive Director
Director Market Access
Attorney-at-law, Senior Director, International TA Policy Strategy
Alexion AstraZeneca Rare Disease
Attorney-at-law, Senior Director, International TA Policy Strategy
Director
Associate Director
Co-Founder and CEO, Realise Advocacy, Director
Senior Technical Consultant in Epidemiology
Founder and CEO
Global Director, Market Access and HEOR
Visiting Lecturer Value Based Pricing & Innovative Contracting of New Medicines
University of Portsmouth
Visiting Lecturer Value Based Pricing & Innovative Contracting of New Medicines
VP Global Program Leader – Health Data Partnerships, Data Science Institute.
Takeda R&D
VP Global Program Leader – Health Data Partnerships, Data Science Institute.
Director
Content Rich Program Agenda! Featuring Keynote Presentations, Stream Sessions, Panel, and Round Table Discussions.
Dr. Marco Rauland, Vice President, Global Value Demonstration, Market Access & Pricing, Merck KGaA
Moderator:
Dr. Marco Rauland, Vice President, Global Value Demonstration, Market Access & Pricing, Merck KGaA
Panelist:
Libby Hamson, Senior Manager, Market Access, Pfizer
Senior Representative, OPTiMAX Access
Elvira Müller, Vice President, Evidence & Access, CERTARA
Santoke Naal, Director Market Access, IGES U.K. Pharma Ltd
Esther Nzenza, Founder and CEO, Decisive Consulting Ltd.
Mitun Patel, Director, Red Nucleus
Higia Vassoler, Associate Director, Red Nucleus
Maarten Van Baelen, Executive Director, Plasma Protein Therapeutics Association
Stephane Read, Sr Technical Consultant, Epidemiology, Certara Evidence & Access
Rafael Souza, Head, Access Solutions & Pricing, New Markets, BeiGene Switzerland
Riad Dirani, VP of Global HEOR, Medical Operations & Excellence, Teva
Moderator:
Matthias Heck, Sr Director, International TA Policy Strategy, Alexion Pharmaceuticals
Santoke Naal, Director Market Access, IGES U.K. Pharma Ltd
Ana Plata, Global Pricing Head – BioPharmaceuticals, AstraZeneca
Claudia Neuber, Head, Global Pricing Oncology, Global Market Access & Pricing, AstraZeneca
Silvy Mardiguian, Market Access Director, UK & Ireland, BeiGene UK
Josie Godfrey, Co-Founder and CEO, Realise Advocacy, Director, JG Zebra Consulting
Frankie Shupo, Global Director, Market Access and HEOR, EUSA Pharma
Maria Danchenko, Global Market Access Academy Lead, Sanofi
Daniel Jackson, Global Head – Market Access Policy, UCB
Antje Emmermann, Executive Director, Market Access Lead, Alexion
Ryotaro Ishikawa, Global Market Access Director, Novartis
Omar Ali, Visiting Lecturer Value Based Pricing & Innovative Contracting of New Medicines, University of Portsmouth
Panelist:
Maria Danchenko, Global Market Access Academy Lead, Sanofi
Daniel Jackson, Global Head – Market Access Policy, UCB
No Spam - You will only receive relevant information on Patient Centricity & Collaboration, and event updates
what people say
Take Advantage of the Super Early Bird Discount. Group Discounts Also Available.